Want to see CTRE full AI Analyst Report?
CTRE Stock Chart & Stats
$43.25
<$0.01(0.02%)
At close: 4:00 PM EDT
$43.25
<$0.01(0.02%)
Day’s Range― - ―
52-Week Range$32.79 - $43.62
Previous CloseN/A
Volume133.00
Average Volume (3M)2.86M
Market Cap
$9.35B
Enterprise Value$10.63K
Total Cash (Recent Filing)$49.27M
Total Debt (Recent Filing)$1.21B
Price to Earnings (P/E)24.6
Beta0.20
Next Earnings
Nov 11, 2026EPS Estimate
0.4Next Dividend Ex-DateN/A
Dividend Yield3.66%
Share Statistics
EPS (TTM)1.61
Shares Outstanding236,293,200
10 Day Avg. Volume2,449,187
30 Day Avg. Volume2,860,777
Financial Highlights & Ratios
PEG Ratio0.25
Price to Book (P/B)1.82
Price to Sales (P/S)15.45
P/FCF Ratio19.43
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$46.50Price Target Upside7.51% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)1.51
Revenue Forecast (FY)$500.00M
Bulls Say, Bears Say
Bulls Say
Free Cash Flow StrengthSustained, high free cash flow (TTM $519M) indicates durable internal funding for dividends, acquisitions, and debt flexibility. With FCF running ~97% of net income, earnings are backed by cash, reducing reliance on volatile external capital and supporting long-term payout and reinvestment strategies.
Improved Balance SheetA materially de-levered balance sheet (TTM zero reported debt) meaningfully improves financial flexibility and lowers refinancing risk. Conservative leverage enhances resilience through cycles, allows opportunistic acquisitions, and supports sustained dividend policy without near-term maturity pressure.
High And Active Investment DeploymentLarge, yield-accretive deployment (Q2 and YTD record investments) demonstrates repeatable origination capability and pipeline depth. Consistent access to attractive assets and the ability to deploy capital at high spreads supports durable FFO/FAD growth and long-term portfolio yield maintenance.
Bears Say
Reliance On Unsettled Equity ForwardsHeavy reliance on unsettled forward equity proceeds to fund guidance and investments creates execution risk if market conditions or settlement mechanics change. Over the medium term this can compress growth or force higher-cost financing, making funding assumptions less reliable.
SHOP Market Competition & Cap-Rate CompressionStructural competition in the SHOP segment compresses underwriting spreads and yields, reducing future return potential on similar acquisitions. Persistent cap-rate tightening can erode accretion from new deals and pressure portfolio yield unless offset by operational improvements or higher-quality assets.
Long-Dated Financing Receivable UncertaintyA material portion of financing receivables includes long-dated purchase options, creating uncertainty on when loans convert to owned real estate. This timing risk complicates long-term cash flow visibility and asset-liability planning, potentially delaying expected yield improvement from conversions.
CareTrust REIT News
CTRE FAQ
What was CareTrust REIT’s price range in the past 12 months?
CareTrust REIT lowest stock price was $32.79 and its highest was $43.62 in the past 12 months.
What is CareTrust REIT’s market cap?
CareTrust REIT’s market cap is $9.35B.
When is CareTrust REIT’s upcoming earnings report date?
CareTrust REIT’s upcoming earnings report date is Nov 11, 2026 which is in 78 days.
How were CareTrust REIT’s earnings last quarter?
CareTrust REIT released its earnings results on Aug 06, 2026. The company reported $0.38 earnings per share for the quarter, missing the consensus estimate of $0.384 by -$0.004.
Is CareTrust REIT overvalued?
According to Wall Street analysts CareTrust REIT’s price is currently Undervalued.
Does CareTrust REIT pay dividends?
CareTrust REIT pays a Quarterly dividend of $0.39 which represents an annual dividend yield of 3.66%. See more information on CareTrust REIT dividends here
What is CareTrust REIT’s EPS estimate?
CareTrust REIT’s EPS estimate is 0.4.
How many shares outstanding does CareTrust REIT have?
CareTrust REIT has 236,293,200 shares outstanding.
What happened to CareTrust REIT’s price movement after its last earnings report?
CareTrust REIT reported an EPS of $0.38 in its last earnings report, missing expectations of $0.384. Following the earnings report the stock price went up 0.219%.
Which hedge fund is a major shareholder of CareTrust REIT?
Currently, no hedge funds are holding shares in CTRE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CareTrust REIT Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$46.50 (7.51% Upside)
$46.50 (7.51% Upside)
Blogger Sentiment
Bullish
CTRE Sentiment 90%
Sector Average 59%
Sector Average 59%
Hedge Fund Trend
Increased
By 326.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.9%
Last 30 Days ▲ 5.7%
Last 30 Days ▲ 5.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
43.90%
12-Months-Change
Fundamentals
Return on Equity
3.66%
Trailing 12-Months
Asset Growth
27.33%
Trailing 12-Months
Company Description
CareTrust REIT
CareTrust REIT, Inc. operates as a self-managed, publicly traded real estate investment trust. The company specializes in the ownership, acquisition, development, and leasing of various healthcare properties, including skilled nursing facilities, seniors' housing complexes, and other related medical real estate. It maintains a broad, nationwide portfolio of assets, all under long-term net lease agreements with an expanding group of reputable operators. CareTrust REIT is actively pursuing strategic growth across the United States, leveraging both external investments and organic expansion opportunities.
CTRE Company Deck
CTRE Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was strongly positive on operational and financial performance: record quarterly investments, robust YTD deployment (~$1.5B), double-digit per-share growth guidance, materially higher normalized FFO/FAD and conservative leverage with ample liquidity. Offsetting items are focused and tactical: competitive pressures and cap rate compression in the SHOP market, modest pricing premium on a large U.K. buy, reliance on unsettled equity forward proceeds and certain guidance assumptions, and multi-year uncertainty around financing receivable purchase options. Overall the strengths (record investment activity, significant FFO/FAD growth, strong balance sheet and operator quality) materially outweigh the select execution and market risks discussed.View all CTRE earnings summariesCTRE Stock 12 Month Forecast
Average Price Target
$46.50
▲(7.51% Upside)
Technical Analysis
National Health Investors
―
Omega Healthcare
―
Sabra Healthcare REIT
―
Healthcare Realty Trust
―
American Healthcare REIT, Inc.
―
Ownership Overview
0.69% Insiders
30.85% Mutual Funds
21.50% Other Institutional Investors
17.72% Public Companies and
Individual Investors